Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03205878
Other study ID # S60283
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 28, 2017
Last updated June 29, 2017
Start date July 1, 2017
Est. completion date December 31, 2019

Study information

Verified date June 2017
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with obstructive sleep apnea (OSA) are less physically active than healthy controls.

First choice of treatment for OSA is continuous positive airway pressure (CPAP) therapy with an improvement in oxygen saturation and sleep. No improvement on physical activity has been shown.

The current study would randomize patients in a standard care group (CPAP) and an intervention group (CPAP + telecoaching). Telecoaching will be performed for 3 months, with physical activity assessment before, after 3 months and 12 years.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 102
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- AHI > 15 events/hour, measured by polysomnography

- < 7,500 steps per day

- Willing to start CPAP treatment

- Age between 18 and 65 years

- Signing the written informed consent

Exclusion Criteria:

- Patients with neuromuscular diseases

- Patients with chronic obstructive pulmonary disease and interstitial lung disease

- Patients with cardiac failure and ischemic heart failure

- Patients with comorbidities which could interfere with a normal biomechanical gait pattern and the possibility of increasing physical activity

- Patients with mental disability making it impossible to understand the study protocol and the use of electronic devices.

Study Design


Intervention

Other:
Telecoaching
Patients in the intervention arm will receive a step counter and a cell phone with an app on which the amount of steps are daily sent to. Initial targets on steps per day will be discussed with the patient after an activity monitoring before the telecoaching procedure. Dependent whether the patient reaches his/her proposed goal each week, new goals are set.
Device:
CPAP
Patients will receive CPAP according to standard care

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Outcome

Type Measure Description Time frame Safety issue
Primary Change in steps per day after 3 months Steps per day as measured by a step counter The change will be measured after 3 months
Secondary The proportion of patients with an increase > 1,000 steps per day After 3 months (end of telecoaching) and after 12 months
Secondary The proportion of patients with > 7500 steps/day Before initiation of telecoaching (baseline), after 3 months (end of telecoaching) and after 12 months
Secondary Change in functional exercise capacity 6-minute walking distance 3 months and 12 months compared with baseline
Secondary Change in daytime sleepiness Epworth Sleepiness Scale 3 months and 12 months compared with baseline
Secondary Change in sleep quality Pittsburgh Sleep Quality Index 3 months and 12 months compared with baseline
Secondary Change in endothelial function Endo-PAT 2000 measurement 3 months and 12 months compared with baseline
Secondary Change in body composition Bodystat 1500 measurement 3 months and 12 months compared with baseline
Secondary Change in quality of life SF-36 questionnaire 3 months and 12 months compared with baseline
Secondary Change in steps per day after 12 months Steps per day as measured by a step counter The change will be measured after 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A